Page 337 - Read Online

Page 10 of 10 Archakova et al. Vessel Plus 2018;2:34 I http://dx.doi.org/10.20517/2574-1209.2018.52

non-diabetic haemodialysis patients--importance of glycaemic control. Diabetologia 2002;45:1446-8.
60. Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ, et al. Kidney disease outcomes quality initiative (K/DOQI) and the
dialysis outcomes and practice patterns study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis 2004;44:39-46.
61. Titan SM, Zatz R, Graciolli FG, dos Reis LM, Barros RT, et al. FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J
Am Soc Nephrol. 2011;6:241-7.
62. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and
risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA
2011;305:1119-27.
63. Qu W, Le TT, Azen SP, Xiang M, Wong ND, et al. Value of coronary artery calcium scanning by computed tomography for predicting
coronary heart disease in diabetic subjects. Diabetes Care 2003;26:905-10.